Researchers have found a way to transform skin cells into fully functioning mature liver cells that grow on their own after being transplanted into mice.
An experimental gene therapy developed by investigators at the Icahn School of Medicine at Mount Sinai successfully regenerated heart muscle in pigs following a heart attack.
A newly discovered mechanism that promotes bone growth could lead to novel treatments for osteoporosis, which affects an estimated one in three women and one in 12 men in the U.S..
Three-dimensional kidney structures created for the first time in a laboratory by scientists at the Salk Institute for Biological Studies could provide a new possibility for developing drugs that treat kidney disease and restore kidney function.
Researchers at the National Institutes of Health have created genetically altered mice that outlive regular mice by about 20%--the equivalent of raising the average human lifespan by 16 years, from 79 to 95.
Scientists may have unlocked a way to therapeutically correct genetic defects by using a new technique that targets and repairs defective genes.
A drug used since the 1960s to treat Type 2 diabetes appears to prolong both life and good health in middle-aged male mice. If further research supports the early results, the discovery could allow doctors to use the drug to stave off metabolic decline in humans as they grow older.
Mesenchymal stem cells are capable of differentiating into bone and cartilage, as well as muscle, fat and tendon. A new technique that tracks stem cells after transplantation may help increase the effectiveness of such procedures.
Researchers at the University of Kentucky Sanders-Brown Center on Aging may have uncovered the mechanism of action behind a kind of experimental Alzheimer's therapy called intravenous immunoglobulin, also known as Gammagard™ IVIg.
Researchers at the Harvard Stem Cell Institute may have discovered a way to reverse symptoms of heart failure, a debilitating condition prevalent in old age.